Breakthrough cancer pain (BTcP) management: a review of international and national guidelines
作者： Andrew Neil Davies , Frank Elsner , Marilène Jeanne Filbet , Josep Porta-Sales , Carla Ripamonti
DOI: 10.1136/BMJSPCARE-2017-001467
关键词:
摘要: … Objective Breakthrough cancer pain (BTcP) is common and has a significant impact on the quality of life of patients with cancer. This review compares current national/international …
elsevier.com
sci-hub.se 参考文章(46)
Simmonds Ma, Pharmacotherapeutic management of cancer pain: current practice. Seminars in Oncology. ,vol. 24, ,(1997)
Andrew N. Davies, Andrew Dickman, Paul Farquhar-Smith, Katherine Webber, John Zeppetella, Incorrect Use of the English Language Term "Episodic'' Journal of Pain and Symptom Management. ,vol. 52, ,(2016) , 10.1016/J.JPAINSYMMAN.2016.06.002
Katherine Webber, Development of a breakthrough cancer pain assessment tool Imperial College London. ,(2013) , 10.25560/18045
Katherine Webber, Andrew N. Davies, Giovambattista Zeppetella, Martin R. Cowie, Breakthrough Pain Assessment Tool PsycTESTS Dataset. ,(2016) , 10.1037/T45232-000
Robert A. Swarm, Judith A. Paice, Doralina L. Anghelescu, Madhuri Are, Justine Yang Bruce, Sorin Buga, Marcin Chwistek, Charles Cleeland, David Craig, Ellin Gafford, Heather Greenlee, Eric Hansen, Arif H. Kamal, Mihir M. Kamdar, Susan LeGrand, Sean Mackey, M. Rachel McDowell, Natalie Moryl, Lisle M. Nabell, Suzanne Nesbit, Nina O’Connor, Michael W. Rabow, Elizabeth Rickerson, Rebecca Shatsky, Jill Sindt, Susan G. Urba, Jeanie M. Youngwerth, Lydia J. Hammond, Lisa A. Gurski, , Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of The National Comprehensive Cancer Network. ,vol. 17, pp. 977- 1007 ,(2019) , 10.6004/JNCCN.2019.0038
Yolanda Escobar Álvarez, Albert Biete i Solà, Manuel Camba Rodríguez, Rafael Gálvez Mateos, Ana Mañas Rueda, César A. Rodríguez Sánchez, Dulce Rodríguez Mesa, Albert Tuca i Rodríguez, Diagnóstico y tratamiento del dolor irruptivo oncológico: recomendaciones de consenso Medicina Paliativa. ,vol. 20, pp. 150- 157 ,(2013) , 10.1016/J.MEDIPA.2013.03.005
C. Delorme, T. Delorme, B. Diquet, M. Filbet, P. Hubault, N. Jovenin, I. Krakowski, J. -F. Morere, S. Rostaing, A. Serrie, P. Poulain, N. Michenot, D. Ammar, Mise au point sur l’utilisation du fentanyl transmuqueux chez le patient présentant des douleurs d’origine cancéreuse (version longue) Douleur Et Analgesie. ,vol. 25, pp. 102- 117 ,(2012) , 10.1007/S11724-012-0287-7
Neal E Slatkin, John Messina, Fang Xie, Thalia J Segal, Fentanyl Buccal Tablet for Relief of Breakthrough Pain in Opioid-Tolerant Patients With Cancer-Related Chronic Pain The journal of supportive oncology. ,vol. 5, pp. 327- 334 ,(2007)
Sebastiano Mercadante, , Paolo Marchetti, Arturo Cuomo, Massimo Mammucari, Augusto Caraceni, Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group Supportive Care in Cancer. ,vol. 24, pp. 961- 968 ,(2016) , 10.1007/S00520-015-2951-Y
Russell K. Portenoy, Neil A. Hagen, Breakthrough pain: definition, prevalence and characteristics Pain. ,vol. 41, pp. 273- 281 ,(1990) , 10.1016/0304-3959(90)90004-W